NeuroPace (NPCE) Asset Writedowns and Impairment (2020 - 2026)
NeuroPace (NPCE) posted Asset Writedowns and Impairment of $68000.0 for Q2 2026, down 10.53% on a QoQ basis from $76000.0 in Q1 2026, and up 38.78% year-over-year from $49000.0 in Q2 2025.
Powered by 
Analysis
NeuroPace (NPCE) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
NeuroPace has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $68000.0 in Q2 2026.
- On a quarterly basis, Asset Writedowns and Impairment rose 38.78% year-over-year to $68000.0 in Q2 2026; TTM through Jun 2026 was $251000.0, a 17.43% decrease from a year earlier, with the FY2025 full-year figure at $200000.0, down 33.33% from the prior year.
- Asset Writedowns and Impairment was $68000.0 for Q2 2026 at NeuroPace, down from $76000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $107000.0 in Q3 2024, with the low at $34000.0 in Q1 2023.
- Average Asset Writedowns and Impairment over 5 years is $60388.9, with a median of $51500.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment jumped 241.67% in 2022, then tumbled 58.54% in 2023.
- Over 5 years, Asset Writedowns and Impairment stood at $39000.0 in 2022, then surged by 74.36% to $68000.0 in 2023, then surged by 52.94% to $104000.0 in 2024, then sank by 42.31% to $60000.0 in 2025, then advanced by 13.33% to $68000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $68000.0 (Q2 2026), $76000.0 (Q1 2026), and $60000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68,000.00 |
| Mar 31, 2026 | 76,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 104,000.00 |
| Sep 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 44,000.00 |
| Jun 30, 2023 | 54,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 35,000.00 |
| Jun 30, 2022 | 87,000.00 |
| Mar 31, 2022 | 82,000.00 |
| Dec 31, 2021 | 57,000.00 |
| Sep 30, 2021 | 23,000.00 |